Skip to main content
. 2019 Feb 4;8:F1000 Faculty Rev-149. [Version 1] doi: 10.12688/f1000research.16654.1

Figure 1. Targeting the vasopressin–AQP2 pathway in water balance disorders.

Figure 1.

Alterations of the vasopressin–AQP2 axis, causes of the disease, and principal effects observed in selected water balance disorders. AQP2, aquaporin-2; CNS, central nervous system; V2R, type 2 vasopressin receptor.